U.S. Representative Tom O’Halleran of Arizona’s 1st Congressional District is one of eighteen Freshman Congressmen who have signed on to a letter asking House Speaker Paul Ryan to consider fast-tracking consideration of H.R. 184, Protect Medical Innovation Act.Continue reading
Category Archives: AZBio News
NuvOx Pharma and Jiangsu Nhwa Pharmaceutical Co., Ltd. Sign Licensing Agreement for Hemorrhagic Shock and Perioperative Blood Loss
NuvOx Pharma and Jiangsu Nhwa Pharmaceutical Co., Ltd. Sign Licensing Agreement for Hemorrhagic Shock and Perioperative Blood Loss
Lurie Children’s Patient is Youngest, Smallest to Receive 50cc SynCardia Total Artificial Heart
At 11 years old, Jaheim Whigham (center) is the youngest and smallest patient to receive the 50cc SynCardia temporary Total Artificial Heart. (Photo: Jan Terry, Ann & Robert H. Lurie Children’s Hospital of Chicago)Continue reading
Hearst Foundation funds TGen research into cancer-related ‘wasting syndrome’
Cachexia responsible for more than 30 percent of deaths in cancer patients
SenesTech is Ramping Things Up
SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control is ramping up manufacturing capabilities to meet demand in 2017 and beyond for the company’s innovative new rodent control technology, ContraPest. The Company’s existing manufacturing capacity, estimated at 300,000 liters per year, is expected to double under the current expansion plans.Continue reading
Venture Madness: Give Our AZBio Members a Thumbs Up
2017 VENTURE MADNESS COMPETITION – VOTE FOR THE PEOPLE’S CHOICE AWARD by 5:00 PM, on January 24thContinue reading
Applications are Open for the Spring 2017 Arizona Innovation Challenge
Submission Window Open through February 17th!!Continue reading
SenesTech Rings the Closing Bell at Nasdaq.
SenesTech, Inc. (Nasdaq: SNES), a developer of novel proprietary technologies for managing animal pest populations through fertility control, visited the Nasdaq MarketSite in Times Square to ring the closing bell on Friday, January 20, 2017.Continue reading
It’s Time to Apply for MedTech Innovator
Applications for 2017 Are Now OpenContinue reading
Castle Biosciences’ New Laboratory Receives Accreditation from College of American Pathologists
Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment decisions, today announced that the Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to its new state-of-the-art laboratory facility in Phoenix, AZ based on results of a recent onsite inspection as part of the CAP’s Accreditation Programs.